Jacob Kilstein

Jacob Kilstein Recent News

Perrigo's Weak Near-Term Outlook Is Concerning
After A 20% Pullback, Now Is The Time To Load Up On Regency Centers
Public Storage Price Target Lowered At Argus On Expected SSS Slowdown
Analysts Prescribe A Downgrade For Pfizer Stock
Argus Slightly Disappointed With Pfizer's Decision Not To Split The Company
Shares Pull Back As Problems Pile Up At Perrigo
Controversy Pullback Offers Good Entry Point For Mylan
Strong Housing Starts And Chinese Demand Bode Well For Weyerhaeuser
Zoetis Capitalizing On Lack Of Competition In Generic Animal Drug Competition
Allstate Looking Very Shareholder-Friendly With Buybacks, Dividend Hike
Regency Stock Is Fully Valued
Vornado Realty Appears Likely To Spin Off D.C. Properties
In Wake Of Medivation Deal, Argus Thinks Pfizer's Existing Business Is Underrated
Argus On Ventas: Looking For A Pullback To $62
Host Hotels May Accommodate Investors With Luxurious Earnings, Dividend Increases
Quintiles Poised To Benefit From Pharmaceutical R&D Outsourcing
Argus Says American Tower Stands Above Its Peers In The Wireless Tower Space
Simon Property Group Just Raised FFO Guidance, Could Raise It Again This Year
Argus Sees A String Of Catalysts Ahead For Amgen, Raises Price Target
Argus Analysts See Strong Opportunities For Ventas, Would Buy On A Pullback
Argus Sees Perrigo Going Lower After CEO Exit, Guidance Cut
Sun Life Financial Still Seeing Strong Results Despite Low Interest Rates
Argus Downgrades United Therapeutics To Hold, Cites 'Challenging Outlook'

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved